High Power Laser on Suboccipital Myoelectrical Activities and Quality of Life in Patients With Cervicogenic Headache
Launched by CAIRO UNIVERSITY · Jan 27, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how high-power laser treatment may help patients who suffer from cervicogenic headaches, which are headaches caused by issues in the neck. The study aims to understand if this laser treatment can reduce pain, improve the muscle activity in the neck area, and enhance the overall quality of life for people experiencing these headaches.
To participate in the trial, you need to be between 30 and 50 years old and have been having cervicogenic headaches at least once a week for the last six months. You should also have specific neck pain that affects the upper cervical area. However, certain conditions, such as other types of headaches or serious neurological issues, may exclude you from participating. If eligible, you can expect to receive high-power laser treatment and be monitored for changes in your pain and quality of life throughout the study. This trial is not yet recruiting participants, but it aims to provide valuable insights into a potential new treatment for cervicogenic headaches.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients suffering from cervicogenic headache based on international headache society "IHS" criteria for cervicogenic headache.
- • Unilateral cervical radiculopathy (Upper cervical C1 -C4).
- • Age ranged from 30 to 50 years.
- • Neck pain referring unilaterally to suboccipital region.
- • The pain and restriction in C1-C2 rotation by Cervical Flexion-Rotation Test (FRT )
- • Intensifying headache by manual pressure to upper cervical muscles and joints.
- • Experiencing headache at least once per week for the last 6 months.
- • Patients will be referred by neurological consultants.
- • Body mass index (18.5 - 29. 9 Kg/m2).
- • Moderate (45-74) to severe (75-100) neck pain on the visual analogue scale.
- Exclusion Criteria:
- • Cervical myelopathy, cervical instability, cervical fracture cervical surgery with evidence of pyramidal, posterior column disorders.
- • History of any neurologic disease ( stroke, MS , cerebellar disorders , vestibular dysfunction and neuropathy )Pregnant or breastfeeding women
- • Other types of headaches (migraine - cluster headaches- tension headache)
- • Patients of systemic diseases such as rheumatoid arthritis
- * contraindication to high-power Laser such as:
- • Wounds or skin changes in the neck or shoulder region (such as psoriasis, scars, or burns).
- • Photosensitivity diagnosis.
- • Tumors of some type have been diagnosed in the last 5 years.
- • Presence of solar urticaria or adverse reactions to sunlight.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Shehab Khadrawy, Professor
Study Director
Al-Azhar University
Asharaf A. Abdelmoneim, Professor
Study Director
Cairo University
Abd El-Aleem A Attia, professor
Study Chair
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported